ROYAL BANK OF CANADA - AYTU BIOPHARMA INC ownership

AYTU BIOPHARMA INC's ticker is AYTU and the CUSIP is 054754874. A total of 43 filers reported holding AYTU BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of AYTU BIOPHARMA INC
ValueSharesWeighting
Q4 2022$0511
+6.7%
0.00%
Q3 2022$0479
+0.6%
0.00%
Q2 2022$0
-100.0%
4760.0%0.00%
Q1 2022$1,0000.0%476
-6.3%
0.00%
Q4 2021$1,0000.0%508
-13.0%
0.00%
Q3 2021$1,000
-96.6%
584
-89.9%
0.00%
Q2 2021$29,000
+93.3%
5,764
+189.6%
0.00%
Q1 2021$15,000
+1400.0%
1,990
+1050.3%
0.00%
Q4 2020$1,0001730.00%
Other shareholders
AYTU BIOPHARMA INC shareholders Q4 2022
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 2,379,936$2,570,0000.05%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 10,880$12,0000.00%
Renaissance Technologies 765,469$827,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 53,530$58,0000.00%
Focused Wealth Management, Inc 209$00.00%
FEDERATED HERMES, INC. 5,633$6,0000.00%
JANICZEK WEALTH MANAGEMENT, LLC 1$00.00%
UBS Group AG 1$00.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 100$00.00%
IFP Advisors, Inc 2,400$16,0000.00%
View complete list of AYTU BIOPHARMA INC shareholders